Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Takeda is taking back the home license for a phase 3-stage depression drug as part of an amendment to its multi-asset ...